Debate: GLP-RA Should Be First Line Therapy for Treatment of Obesity

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Debate: GLP-RA Should Be First Line Therapy for Treatment of Obesity

By Cedars Sinai FEATURING Martha Gulati

0 views

June 4, 2024

Comments 1

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Discover the MOA of an Incretin Medication for T2D

Carbs: Are They the Enemy? Processed vs Unprocessed vs None

47:11

Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis

64:45

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi

13:54

Neal Barnard

Dietary Cholesterol

49:21

Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key

28:13

National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason

17:21

Ilene Fennoy

Obesity and Diabetes in Children

13:57

4th Annual Cardiovascular Conference: Advances in Cardiovascular Disease - from Prevention to Intervention

Intermittent Fasting: What Is the Evidence for Efficacy and Cardiome…

Feat. J. Kane

13:14

Monica Aggarwal

Dairy: What's the Data Say

13:58

Matthew Budoff

Coronary CTA for Assessing CAD - Are We There Yet?

18:43

ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo

15:06

Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

12:26

Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

18:44

ACR Convergence 2021 Coverage

Calcium and Vitamin D Supplementation to Prevent and Manage Osteopor…

Feat. N. Lane

45:55

3rd Annual Montefiore Einstein Preventive Cardiology Conference

Plant Based Living: Exponential Growth in Acceptance and Knowledge

Feat. A. Freeman

15:33

Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

27:24

Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan

26:49

Diana Isaacs

Tirzepatide Updates

16:30

ACC 2023 Conference Coverage

ACC 2023: Mediterranean-Style Diet and Cardiovascular Disease Risk

Feat. R. Ostfeld

11:55

Caldwell Esselstyn

Login

Login

Join VuMedi

Debate: GLP-RA Should Be First Line Therapy for Treatment of Obesity

Recommended